The Filing Desk

Acadia Pharmaceuticals vs Neonc Technologies Holdings

Acadia Pharmaceuticals ACAD · Neonc Technologies Holdings NTHI · Pharmaceuticals

Acadia Pharmaceuticals' revenue grew 11.9% in its latest year, and Neonc Technologies Holdings' fell 51.8%. Acadia Pharmaceuticals had an operating margin of 9.8%, against -145637.5% at Neonc Technologies Holdings. Free cash flow was $105 million at Acadia Pharmaceuticals and −$21 million at Neonc Technologies Holdings.

Side by side

Acadia PharmaceuticalsNeonc Technologies Holdings
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.1B$0M
Revenue growth11.9%−51.8%
Revenue growth a year, last 5 years19.4%—
Gross margin91.7%—
Operating margin9.8%−145,637.5%
Net margin36.5%−155,404.4%
Free cash flow$105M−$21M
Free cash flow margin9.8%−52,172.9%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count2.1%11.9%
Last close$17.59$3.48
P/E at the last close8.3×—
Insider trades, last 12 monthssold $2.5 millionbought $1.3 million, sold $16,800
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Acadia PharmaceuticalsNeonc Technologies Holdings
Operating margin
Percent of revenue
Acadia PharmaceuticalsNeonc Technologies Holdings
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Acadia PharmaceuticalsNeonc Technologies Holdings

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Acadia Pharmaceuticals and Neonc Technologies Holdings pages.